| Drug Type Small molecule drug | 
| Synonyms iloma, 이로마정 | 
| Target | 
| Action antagonists, inhibitors | 
| Mechanism FXR antagonists(Bile acid receptor FXR antagonists), Proton pump inhibitors | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhaseApproved | 
| First Approval Date South Korea (21 Apr 2025),  | 
| Regulation- | 
| Molecular FormulaC24H40O4 | 
| InChIKeyRUDATBOHQWOJDD-UZVSRGJWSA-N | 
| CAS Registry128-13-2 | 
| Indication | Country/Location | Organization | Date | 
|---|---|---|---|
| Abdomen distended | South Korea  | 21 Apr 2025 | |
| Anorexia | South Korea  | 21 Apr 2025 | |
| Constipation | South Korea  | 21 Apr 2025 | |
| Hemorrhoids | South Korea  | 21 Apr 2025 | 





